about
MiniCD4 microbicide prevents HIV infection of human mucosal explants and vaginal transmission of SHIV(162P3) in cynomolgus macaquesIncreasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silicaOrdered mesoporous silica induces pH-independent supersaturation of the basic low solubility compound itraconazole resulting in enhanced transepithelial transportMultidrug resistance-associated protein 2 (MRP2) affects hepatobiliary elimination but not the intestinal disposition of tenofovir disoproxil fumarate and its metabolitesEnhanced release of itraconazole from ordered mesoporous SBA-15 silica materialsOrdered mesoporous silica material SBA-15: a broad-spectrum formulation platform for poorly soluble drugsDownscaling drug nanosuspension production: processing aspects and physicochemical characterization.Screening of Tanzanian plant extracts for their potential inhibitory effect on P-glycoprotein mediated efflux.High-speed digital imaging method for ciliary beat frequency measurement.Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25.Synthesis and characterisation of inulin-azo hydrogels designed for colon targeting.Characterization of glassy itraconazole: a comparative study of its molecular mobility below T(g) with that of structural analogues using MTDSC.Beneficial effect of antibiotics on ciliary beat frequency of human nasal epithelial cells exposed to bacterial toxins.In vivo, in vitro and in silico methods for small molecule transfer across the BBB.Enhanced performance for the analysis of prostaglandins and thromboxanes by liquid chromatography-tandem mass spectrometry using a new atmospheric pressure ionization source.Atmospheric Pressure Ionization Using a High Voltage Target Compared to Electrospray Ionization.An atmospheric pressure ionization source using a high voltage target compared to electrospray ionization for the LC/MS analysis of pharmaceutical compounds.In vitro hepatic metabolism explains higher clearance of voriconazole in children versus adults: role of CYP2C19 and flavin-containing monooxygenase 3Food-dependent disintegration of immediate release fosamprenavir tablets: in vitro evaluation using magnetic resonance imaging and a dynamic gastrointestinal system.Molecular organization of hydrophobic molecules and co-adsorbed water in SBA-15 ordered mesoporous silica material.Cardiovascular disease relates to intestinal uptake of p-cresol in patients with chronic kidney disease.Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1.Growth of itraconazole nanofibers in supersaturated simulated intestinal fluid.Determination of OATP-, NTCP- and OCT-mediated substrate uptake activities in individual and pooled batches of cryopreserved human hepatocytes.Sodium fluorescein is a probe substrate for hepatic drug transport mediated by OATP1B1 and OATP1B3.Sandwich-cultured hepatocytes: utility for in vitro exploration of hepatobiliary drug disposition and drug-induced hepatotoxicity.Structure-based identification of OATP1B1/3 inhibitors.The Influence of Dietary Protein Intake on Mammalian Tryptophan and Phenolic Metabolites.Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?The effect of food components on the absorption of P-gp substrates: a review.In vitro disposition profiling of heterocyclic compounds.The Influence of CKD on Colonic Microbial Metabolism.The use of human nasal in vitro cell systems during drug discovery and development.The Influence of Prebiotic Arabinoxylan Oligosaccharides on Microbiota Derived Uremic Retention Solutes in Patients with Chronic Kidney Disease: A Randomized Controlled TrialBile Salt Micelles and Phospholipid Vesicles Present in Simulated and Human Intestinal Fluids: Structural Analysis by Flow Field-Flow Fractionation/Multiangle Laser Light Scattering.Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD.Microbiota-Derived Phenylacetylglutamine Associates with Overall Mortality and Cardiovascular Disease in Patients with CKD.Drug disposition and modelling before and after gastric bypass: immediate and controlled-release metoprolol formulationsDevelopment of enteric-coated fixed dose combinations of amorphous solid dispersions of ezetimibe and lovastatin: Investigation of formulation and process parameters.Metabolism, Protein Binding, and Renal Clearance of Microbiota-Derived p-Cresol in Patients with CKD.
P50
Q27339377-242244BF-E072-4034-A1DD-29D547BDF939Q28263078-BF848672-15CB-4B40-AE1E-D74A1CC637EAQ28271855-440DA597-F47B-4E04-8D37-5953E2173195Q28289901-2FA89E8D-0EAD-4CC5-B437-2A827440C39FQ28294233-27621037-1F1D-4C7D-B2FB-537377E85B37Q28303560-64ED7A0E-20EB-41CF-B65A-91AF711F7DC0Q30478736-2DE28C13-900C-4FA5-B1C4-5C633F9B7DF6Q30931304-959F305C-4E40-4B71-B5F5-085FD4C6E765Q31159981-815AA0A4-29C6-4783-AD75-38C21A2840CBQ31674692-1117EE76-9B53-4693-82FA-896C861FF507Q31876442-E92C4C74-A0D3-4D79-B677-88C3AEF82CF9Q31876488-7CC1024E-9BC0-4592-BB02-98856129E488Q33326488-6743567E-3912-4EB1-9BFF-33EA823CADA2Q33437761-B0FFE063-98F4-4494-A8D1-28E46948AA6CQ33467397-39D334FB-9D88-45DD-9FEA-79A0FA2AE0EEQ33469344-69E849E2-F2D4-45C5-818B-563276AE4651Q33470520-5DA3E6FA-FEC7-4958-9B47-FA818B841FB7Q33574651-42B03543-CD87-4422-A5A7-06571FB99BD1Q33740194-8CA95345-1BAA-47C9-B971-8C134AA9FA1CQ33770353-2795E57A-0211-4F02-8BD9-BB624EF95893Q33780255-4A2D401B-A33A-4D14-A7DE-645DFB627E86Q34094825-D66F5BF7-93D1-48A7-80A2-39ABC1F51C5FQ34104244-952EDFA4-B97E-47DD-9D32-6C0CBB1DA3F6Q34186809-3D9C9674-0370-4BF4-8DDF-438DA25F1486Q34207673-FBFBA116-A332-44F1-AC3E-F374894BE3FAQ34330504-2CC5A341-F0B6-4BA2-99AB-6D3155CDECD3Q34338211-6D7ABCA0-0C93-44EF-A4CC-D4629B4CBEB4Q34498094-719C66A9-0689-41A9-B7E7-E9A961DEF54DQ34976310-B957FB45-A2C3-4E61-9EFA-3B080FCBECA4Q35083696-1E550BE2-D8A9-4AB9-ACBE-650ACB9B387CQ35653110-BCCB6131-63DF-455E-B6B9-0BAFA92BD622Q35786047-0C6F005C-5DB1-467D-BA01-2ED7BB1AEF7CQ35974939-C44FBA6B-08A4-4E6B-8ED1-D48D522FA8B1Q35995858-82581B69-6A05-4A60-BFBC-46375C01F750Q35996590-05E068D3-0FD0-48A9-B9A3-1A07997FEE26Q36025615-549EFFFC-5BFE-4A8F-BE61-09842424CF32Q36031714-59D3DD78-E86C-4584-AC26-7C124A72F9B5Q36243622-212A43ED-5E22-4AF4-BC4F-0617400EDFD9Q36268362-BB2D3172-314B-4DAA-B832-C3910DB1F17DQ37069948-67A9A7FC-502A-436A-8A42-519868A22CAD
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Patrick F Augustijns
@ast
Patrick F Augustijns
@en
Patrick F Augustijns
@es
Patrick F Augustijns
@nl
Patrick F Augustijns
@sl
type
label
Patrick F Augustijns
@ast
Patrick F Augustijns
@en
Patrick F Augustijns
@es
Patrick F Augustijns
@nl
Patrick F Augustijns
@sl
prefLabel
Patrick F Augustijns
@ast
Patrick F Augustijns
@en
Patrick F Augustijns
@es
Patrick F Augustijns
@nl
Patrick F Augustijns
@sl
P1053
H-7615-2018
P106
P2038
Patrick_Augustijns
P21
P31
P3829
P496
0000-0003-2595-388X